BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7682859)

  • 1. Induction of neutrophil alkaline phosphatase gene expression by granulocyte colony-stimulating factor in chronic myelogenous leukemia.
    Tsushita K; Hotta T; Ichikawa A; Murate T; Saito H
    Int J Hematol; 1993 Jan; 57(1):45-52. PubMed ID: 7682859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor suppresses induction of neutrophil alkaline phosphatase synthesis by granulocyte colony-stimulating factor.
    Teshima T; Shibuya T; Harada M; Akashi K; Taniguchi S; Okamura T; Niho Y
    Exp Hematol; 1990 May; 18(4):316-21. PubMed ID: 1691103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic acid acts to neutralize the inhibitory effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on alkaline phosphatase activity of neutrophils that is induced by granulocyte colony-stimulating factor (G-CSF).
    Mizukami H; Sato N
    Exp Hematol; 1992 May; 20(4):482-5. PubMed ID: 1373689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
    Lee J; Kim Y; Lim J; Kim M; Han K
    Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of neutrophil alkaline phosphatase-inducing factor in cystic fluid of a human squamous cell carcinoma as granulocyte colony-stimulating factor.
    Sato N; Asano S; Koeffler HP; Yoshida S; Takaku F; Takatani O
    J Cell Physiol; 1988 Nov; 137(2):272-6. PubMed ID: 2461375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by retinoids and interferons of alkaline phosphatase activity in granulocytes induced by granulocyte colony-stimulating factor.
    Sato N; Takatani O; Koeffler HP; Sato H; Asano S; Takaku F
    Exp Hematol; 1989 Mar; 17(3):258-62. PubMed ID: 2465168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukaemia is not dependent on p210 tyrosine kinase activity.
    Dotti G; Garattini E; Borleri G; Masuhara K; Spinelli O; Barbui T; Rambaldi A
    Br J Haematol; 1999 Apr; 105(1):163-72. PubMed ID: 10233380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of G-CSF on the proliferation and differentiation of bcr/abl(+)-CD34+ cells from CML patients].
    Li CY; Meng FY; Sun QX; Fu YB; Jiang QL; Yi ZS; Song LL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):762-5. PubMed ID: 18457269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
    Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
    Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic myelogenous leukemia (CML) associated with granulocyte colony-stimulating factor (G-CSF)-producing mesothelioma.
    Masuda Y; Kizaki M; Ueno H; Mori S; Takayama N; Muto A; Matsushita H; Ikeda E; Kawai Y; Ikeda Y
    Leukemia; 1995 Sep; 9(9):1591-4. PubMed ID: 7544855
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of mRNA levels of alkaline phosphatase gene in neutrophilic granulocytes by granulocyte colony-stimulating factor and retinoic acid.
    Sato N; Mizukami H; Tani K; Asano S
    Eur J Haematol; 1991 Feb; 46(2):107-11. PubMed ID: 1704851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of granulocyte colony-stimulating factor in patients after allogeneic bone marrow transplantation for chronic myeloid leukemia correlate with engraftment of transplanted marrow.
    Busch FW; Pilgrim TB; Krämer A; Ehninger G
    Bone Marrow Transplant; 1997 Apr; 19(7):653-9. PubMed ID: 9156241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survey of one hundred patients with chronic granulocytic leukemia from the view of recent developments].
    Jakab K; Triska E; Kelemen E
    Orv Hetil; 1995 Jan; 136(4):171-5. PubMed ID: 7532845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
    Katagiri T; Miyazawa K; Uchida Y; Hayashi S; Iwama H; Shyohji N; Kawakubo K; Shimamoto T; Inatomi Y; Kuriyama Y; Yaguchi M; Nehashi Y; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1998 Dec; 39(12):1149-56. PubMed ID: 10028846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of leukocyte alkaline phosphatase gene in normal and leukemic cells: regulation of the transcript by granulocyte colony-stimulating factor.
    Rambaldi A; Terao M; Bettoni S; Tini ML; Bassan R; Barbui T; Garattini E
    Blood; 1990 Dec; 76(12):2565-71. PubMed ID: 1702329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
    Heuft HG; Goudeva L; Blasczyk R
    Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.